Monoclonal antibodies and Fc fragments for treating solid tumors
Andrea M Eisenbeis, Stefan J GrauDepartment of Neurosurgery, University Hospital of Cologne, Cologne, GermanyAbstract: Advances in biotechnology, better understanding of pathophysiological processes, as well as the identification of an increasing number of molecular markers have facilitated the use...
Guardado en:
Autores principales: | Eisenbeis AM, Grau SJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/009d04495ef04c1abc9614686dbac149 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies
por: Yuan Li, et al.
Publicado: (2010) -
Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
por: Cruz E, et al.
Publicado: (2019) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka T, et al.
Publicado: (2014) -
Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman WL
Publicado: (2021) -
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
por: Elsbernd PM, et al.
Publicado: (2021)